Clinical Studies

AMARIN FISH OIL STUDY: (ENROLLMENT OPEN)

A Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of AMR101 on Cardiovascular Health and Mortality in Hypertriglyceridemic Patients with Cardiovascular Disease or at High Risk for Cardiovascular Disease: REDUCE-IT (Reduction of Cardiovascular Events with EPA – Intervention Trial)

CIRT STUDY ( ACTIVE AND ENROLLMENT OPEN)

A randomized, double-blind, placebo-controlled, event-driven trial of weekly low-dose methotrexate (LDM) in the prevention of recurrent cardiovascular events among stable post-myocardial infarction patient patients with type 2 diabetes or metabolic syndrome.

ORBIT STUDY (ACTIVE AND ENROLLMENT OPEN)

Outcomes Registry for Better Quality of Care in the Treatment of Atrial Fibrillation II

FIBROMYALGIA STUDY (ACTIVE AND ENROLLMENT OPEN)

An open-label extension study for DS-5565 for 52 weeks in pain associated with Fibromyalgia.

HAVE YOU SUFFERED A HEART ATTACK ?

Have you suffered a heart attack?

If so, did you know...   Even though your doctor may have you on an aggressive treatment plan, your risk of having a second heart attack or suffering a stroke may still be HIGH. This increased risk may be related to high levels of inflammation in your blood vessels.

What is CIRT?

CIRT, is a randomized trial. This means, half of all participants will receive an active study drug and half will receive an inactive study drug know as placebo. The study medication is a widely used anti-inflammatory therapy for rheumatoid arthritis with a well documented safety profile.

Main Goal

To see if reducing inflammation can lower your risk of having a second heart attack, a stroke, or dying from heart disease.

Am I eligible?

You may be eligible to participate, if you have had a heart attack in the past 5 years and you have been diagnosed with either diabetes or metabolic syndrome.

Choosing to participate

If you choose to participate in CIRT, you will be followed for up to 5 years. During that period, you will receive all of your usual medical care. Additionally, you will receive special calendar packs which contain the study medications and you will be closely monitored by the study team for safety.

For more information, please discuss CIRT with your physician or contact us... 

DiGiovanna Institute for Medical Education & Research

1061 North Broadway, North Massapequa, NY 11758

Ph:  516-420-4300 and ask for research

email: This email address is being protected from spambots. You need JavaScript enabled to view it.

FIBROMYALGIA

Fibromyalgia

Constipation Clinical Study

If you've been "stopped" by chronic constipation for at least 3 months, local study doctors around the country need your help with the CIC3 research study, To pre-qualify for this research study you must be between 18 and 80 years old and have had chronic constipation for at least three months, to learn more about The CIC3 Study and to see if it's right for you.

CALL DiGIOVANNA INSTITUTE FOR MEDICAL EDUCATION & RESEARCH At 5164204300

That number again is 516-420-4300.

or visit us at www.dfccresearch.com

Again that's 516-420-4300 or visit us at www.dfccresearch.com

REDUCE-IT AMARIN STUDY

Are you at risk for a heart attack or stroke? !

These life-changing events can happen at any time to anyone.  That's why physicians at DiGiovanna Family Care are conducting a research study to determine if an investigational medication reduces your risk of having a heart attack,  stroke, or other cardiovascular events.

You may qualify for participation in this study if you:

  • Are age 45 or older
  • Are taking cholesterol lowering medications(statins)
  • Have elevated triglycerides

 

And have a history of one or more of the following:

  • Previous heart attack or stroke
  • Heart disease
  • Diabetes

 

All study-related care and study medication will be provided at no cost to chosen participants.

To learn more,  please contact: 516-420-4300 and ask for research

Research Studies

Bottom ModuleClinical Trial protocols call for specific "visit windows" which means participants are given special attention      More

Volunteering

Bottom ModuleThe factors that allow volunteers to participate in a clinical trial are called " inclusion criteria" and              More

Safety & Privacy

Bottom ModuleThe FDA works to protect Safety and privacy in clinical trials and to ensure that people have reliable info.More

Contact Us

Bottom ModuleIf you or someone might be interested in participating in a Clinical Trial, Contact us                   More